Latest Insurance News

Page 4 of 67
Vital Metals has extended rare earth and niobium mineralisation beyond Tardiff’s 192.7 million tonne resource envelope, strengthening the case for an updated resource estimate and pre-feasibility study. But the ASX-listed developer ended September with A$2.4 million in cash, equivalent to just 1.87 quarters of funding before higher arbitration costs.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Control Bionics has begun converting its expanded product and regulatory pipeline into revenue, while a completed $9.75 million capital raising gives the company a larger cash buffer. The next test is whether partner-led sales and NeuroStrip trial conversions can reduce its cash burn as planned.
Victor Sage
Victor Sage
29 Oct 2026
MGX Resources has moved from planning to construction at its Central Tanami gold project while completing its final Koolan Island iron ore shipments. The company ended the September quarter with $408.7 million in cash and investments, but key value milestones now depend on drilling, approvals and the Crestlink sale settling.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Suncorp expects FY27 gross written premium growth of around 3%, despite losing a $125 million commercial contract and facing a weaker New Zealand dollar. The insurer maintained its forecast for an underlying insurance trading result margin in the top half of its 10-12% target range and confirmed a $250 million buyback is underway.
Victor Sage
Victor Sage
29 Oct 2026
IMEXHS has moved several proprietary AI agents into live customer use while delivering stronger revenue, earnings and operating cash flow in the third quarter. But software bookings fell sharply, ARR was flat after churn, and Colombian receivables remain a material cash risk.
Victor Sage
Victor Sage
28 Oct 2026
MCS Services reported a $467,000 net cash outflow for the September quarter, leaving $1.305 million in cash and no operating business after its Traffic Business sale. Its securities remain suspended while the company explores a potential acquisition and ASX recompliance transaction with no agreement yet signed.
Victor Sage
Victor Sage
27 Oct 2026
DataDot Technology Limited (ASX:DDT) delivered a stronger FY26, with revenue rising 14.1% to $3.85 million and profit before tax nearly tripling to $327,420. The sharper result was driven largely by PropertyVAULT’s first full year of insurance services, although key insurer relationships remain pilots or works in progress.
Sophie Babbage
Sophie Babbage
26 Oct 2026
Kaiser Reef produced 6,263 ounces of gold in the September quarter while lifting cash and bullion to A$40 million and fully repaying its Auramet gold loan after quarter end. Henty replaced mined reserves, while Maldon’s exploration program moved underground despite a negative operating cash contribution.
Maxwell Dee
Maxwell Dee
26 Oct 2026
FINEOS lifted its quarterly client receipts 47% and ended September with €51.7 million in cash, while maintaining FY26 revenue guidance of €147 million to €152 million. The stronger cash position was helped by the delayed collection of approximately €8 million in invoices, but no new sales were finalised during the quarter.
Victor Sage
Victor Sage
26 Oct 2026
Artrya has converted its largest US customer and first SAPPHIRE Study participant into a five-year commercial agreement, while delaying its planned Coronary Flow FDA submission to strengthen clinical evidence. The Salix rollout is gaining traction, but revenue remains early and scan volumes are undisclosed.
Victor Sage
Victor Sage
26 Oct 2026
Dubber reported $1.3 million of positive operating cash flow in Q1 FY27, alongside $7.7 million in revenue and $16.2 million of total liquidity. The company is now shifting from cost reduction towards growth, with new AI products and the proposed Daisee acquisition next in line.
Sophie Babbage
Sophie Babbage
26 Oct 2026
Cochlear has reaffirmed FY27 underlying net profit guidance of $330 million to $350 million after a disappointing FY26, while pointing to strong Nexa adoption and progress on fully implantable hearing technology. The company is cutting fixed costs and expanding medical referral pathways as it seeks to convert a large pool of untreated adult hearing loss into growth.
Victor Sage
Victor Sage
26 Oct 2026

Browse the archive

Full archive